Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Clinical and Economic Advantages of Modern Dosage Forms: Improving Medication Adherence

This paper examines a substantial source of waste and inefficiency in health care: patient nonadherence with medications. The authors explore how modern drug delivery technology can help improve adherence by simplifying the dosing regimen, and/or decreasing side effects. Other advantages of improved delivery technology include steadier drug concentrations in the bloodstream and targeted delivery of medication to its site of therapeutic action in the body. Authors note important innovations including sustained release medications, transdermal patch, melting tablets, inhaled medications, and others, and the clinical areas in which these innovations apply.

Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Newsletter Volume

E.V.I.dently November 2013

MessageCER Collaborative Is Assessing Evidence and Informing Decision-MakingToday we’re faced with an ever-growing availability of health information...
Newsletter Volume

E.V.I.dently October 2013

Message from NPCWhen Health Insurance Exchange “Dust” Settles, Usable CER Will Be CriticalBy Dan LeonardOn October 1, the debut of the federal...
Blog Post

AMCP 2013 Nexus: Addressing Critical Pharmacy Issues

Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a...
Press Release

National Pharmaceutical Council Welcomes Amgen as Its Newest Member

Washington, D.C. (January 16, 2013)—The National Pharmaceutical Council (NPC) today welcomed biotechnology pioneer Amgen as its newest member. Joshua...
Press Release

Leading Researchers Outline Principles for Conduct of Comparative Effectiveness Research

WASHINGTON, DC (September 11, 2012)—A new set of principles developed by a group of leading researchers could help to ensure more consistency in how...
Press Release

Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals

WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...
Press Release

National Pharmaceutical Council Expands Policy and Research Staff

WASHINGTON, DC (January 4, 2012) -- The National Pharmaceutical Council (NPC) announced the hiring of Daryl Pritchard, PhD, as the Director of...
Commentary and Testimony Page

Comparative Effectiveness Research and the Changing Health Care Landscape

This content appeared in the January 2, 2012 print edition of Chain Drug Review. In the span of just one year, the health care landscape has...
Commentary and Testimony Page

CER: Who Can Say What, and When Can They Say It?

With billions of dollars in comparative effectiveness research (CER) set for completion in coming years, there will be broader discussions about the...
Commentary and Testimony Page

Linking Chronic Conditions to Medication Adherence and Productivity

It's no secret that chronic disease is the major driver of health care costs in the United States, accounting for two-thirds of the rise in health...
Commentary and Testimony Page

Proposed ACO Rules Raising More Questions Than Answers

This month, Washington, DC, has been buzzing about “ACOs” – accountable care organizations – now that the Centers for Medicare and Medicaid Services...
YouTube Videos

Ensuring Inclusive and Diverse Research

Andre Williams, CEO of the Association of Black Cardiologists explains that research should be inclusive and diverse, taking racial, ethnic and...
YouTube Videos

Challenges in Communicating Comparative Effectiveness Research

Dr. Robert Dubois, Chief Science Officer, National Pharmaceutical Council (NPC), describes the issue of "asymmetry" in the comparative effectiveness...
YouTube Videos

CER and Its Impact on Pharma Innovation

Dr. Darius Lakdawalla, director of research at the Schaeffer Center for Health Policy and Economics at the University of Southern California,...
Blog Post

The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes

Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into...
Blog Post

AMCP 2013 Nexus: Addressing Critical Pharmacy Issues

Specialty pharmacy, health care reform, clinical breakthroughs and research in managed care are among the featured topics at the AMCP 2013 Nexus, a...
Blog Post

Catch These Upcoming Events and Publications

September was a particularly busy month, featuring a variety of health care conferences, meetings, publications, and ongoing debates about the...
Blog Post

One Year Later: The FDA Safety and Innovation Act

We're pleased to share with you a guest post from Cynthia Bens, vice president, public policy, Alliance for Aging Research. It’s been a little over a...

Research

Imputing Productivity Gains From Clinical Trials

Researchers developed a new method to capture the impact that medicines may have on reducing the...

Role of Pharmaceuticals in Value-Based Healthcare: A Framework for Success

This research sets out a conceptual framework for considering the role of pharmaceuticals in...

Pharmaceutical Technology Assessment: Perspectives From Payers

The processes and evidence used in making pharmaceutical coverage decisions vary substantially...
  •  
  • 1 of 12
  • >

Commentary & Testimony